Abstract
Human mobility is the fuel of global pandemics. In this simulation study, we analyze how mobility restrictions mitigate epidemic processes and how this mitigation is influenced by the epidemic’s degree of dispersion.
We find that (even imperfect) mobility restrictions are generally efficient in mitigating epidemic spreading. Notably, the effectiveness strongly depends on the dispersion of the offspring distribution associated with the epidemic. We also find that mobility restrictions are useful even when the pathogen is already prevalent in the whole population. However, also a delayed implementation is more efficient in the presence of overdispersion. Conclusively, this means that implementing green zones is easier for epidemics with overdispersed transmission dynamics (e.g., COVID-19). To study these relationships at an appropriate level of abstraction, we propose a spatial branching process model combining the flexibility of stochastic branching processes with an agent-based approach allowing a conceptualization of locality, saturation, and interaction structure.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This is theoretical work. No clinical study was conducted.
Funding Statement
This work was partially supported by the DFG project MULTIMODE.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a theoretical study. As is customary, there was no oversight.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
{gerrit.grossmann{at}uni-saarland.de, michael.backenkoehler{at}uni-saarland.de, verena.wolf{at}uni-saarland.de}
Data Availability
This is a theoretical study using only synthetically generated data. The procedures are described in detail in the manuscript.
